Lazertinib mesylate (Standard)

Overview

Lazertinib mesylate (Standard) is the analytical standard of Lazertinib (mesylate) ( HY-109061B ). This product is intended for research and analytical applications. Lazertinib (YH25448) mesylate is a potent, selective, CNS-penetrant, orally available and irreversible EGFR tyrosine K i nase inhibitor, exhibiting high selectivity for activating (EGFRm) and T790M resistance mutations. Lazertinib mesylate inhibits phosphorylation of EGFR , AKT and ERK , leading to apoptosis and suppression of tumor growth in mouse H1975-luc brain metastasis xenograft models. Lazertinib mesylate can be used in the study of non-small cell lung cancer .

Application

Products | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-109061BR
• CAS No.: 2247995-37-3
• Molecular Formula: C31H38N8O6S
• Molecular Weight: 650.75
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source